On November 1, 2021 Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, reported that members from the Replimune management team will present and host investor meetings at the following two conferences (Press release, Replimune, NOV 1, 2021, View Source [SID1234594024]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
BMO Biopharma Spotlight Series: Emerging Trends & Therapeutics in Oncology
Panel: Pioneering the Next Generation of Oncolytic Virus Therapeutics
Date: Monday, November 8, 2021
Time: 12:45 pm ET
Piper Sandler 33rd Virtual Annual Healthcare Conference
Date: Tuesday, November 30 through Thursday, December, 2021
A pre-recorded fireside chat will be available on-demand beginning on Monday, November 22nd at 10:00 am ET
A simultaneous webcast and replay of the fireside chat at the Piper Sandler 33rd Annual Healthcare Conference will also be available in the Investors section of Replimune’s website at www.replimune.com.